YorkSpace
York University's Institutional Repository
    • English
    • français
  • English 
    • English
    • français
  • Login
View Item 
  •   YorkSpace Home
  • Faculty of Health
  • Department of Psychology
  • View Item
  •   YorkSpace Home
  • Faculty of Health
  • Department of Psychology
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Inclusion of authorized deception in the informed consent process does not affect the magnitude of the placebo effect for experimentally induced pain

Thumbnail
View/Open
KAT117.pdf (986.3Kb)
Date
2010
Author
Martin, Andrea L.
Katz, Joel cc

Metadata
Show full item record
Abstract
The ethics of placebo research have been of paramount concern since the discovery of the phenomenon. To address these ethical concerns, Miller and colleagues (PLoS Med 2005 Sep;2(9):e262, 0853–0859) propose an alternate approach to placebo research, called “authorized deception”, in which participants are alerted of the use of deception in the research prior to study enrollment and thus knowingly permit its use if they decide to participate. The present study sought to investigate the authorized deception methodology in experimentally induced placebo analgesia. The participants were randomly assigned to an authorized deception or non-authorized deception group. A commonly used protocol was employed wherein heat pain stimulation was surreptitiously lowered following the application of a placebo cream during a series of conditioning trials and the magnitude of the placebo effect was subsequently assessed in test trials for which the stimulus intensity was the same for both the placebo and control creams. Authorized deception did not have any negative impact on the magnitude of the placebo effect, recruitment and retention of participants, nor did it result in any significant psychological harm. The majority of participants who received this form of consent preferred it to the traditional approach in which the participants are not alerted to the presence of deception. These findings suggest that the use of authorized deception is a viable and ethically preferable alternative consent process for laboratory-based studies on placebo analgesia. Further studies are needed to examine the effect of authorized deception in clinical trials and other placebo research within a clinical setting.
URI
http://hdl.handle.net/10315/7987
Collections
  • Department of Psychology

All items in the YorkSpace institutional repository are protected by copyright, with all rights reserved except where explicitly noted.

YorkU LogoContact Us | Send Feedback
Sitemap for search engines

 

Browse

All of YorkSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Statistics

View Usage Statistics

All items in the YorkSpace institutional repository are protected by copyright, with all rights reserved except where explicitly noted.

YorkU LogoContact Us | Send Feedback
Sitemap for search engines